Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $419.73 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myriad Genetic Laboratories, Inc. | $148.07 | 2 | $0 (2022) |
| Genentech USA, Inc. | $144.30 | 1 | $0 (2022) |
| Roche Diagnostics Corporation | $87.46 | 1 | $0 (2023) |
| Abbott Laboratories | $24.26 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $15.64 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $87.46 | 1 | Roche Diagnostics Corporation ($87.46) |
| 2022 | $268.89 | 2 | Genentech USA, Inc. ($144.30) |
| 2021 | $23.48 | 1 | Myriad Genetic Laboratories, Inc. ($23.48) |
| 2019 | $39.90 | 2 | Abbott Laboratories ($24.26) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/18/2023 | Roche Diagnostics Corporation | — | Food and Beverage | In-kind items and services | $87.46 | General |
| Category: None | ||||||
| 09/22/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $144.30 | General |
| 08/18/2022 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $124.59 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 07/30/2021 | Myriad Genetic Laboratories, Inc. | myChoice CDx (Device) | Food and Beverage | Cash or cash equivalent | $23.48 | General |
| Category: Tumor DNA Genetic Oncology Analysis | ||||||
| 12/31/2019 | Abbott Laboratories | Optis Coronary Imaging System (Device) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 08/20/2019 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: ONCOLOGY | ||||||
About Dr. Ruben Delgado, MD
Dr. Ruben Delgado, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2019. The National Provider Identifier (NPI) number assigned to this provider is 1386294171.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ruben Delgado, MD has received a total of $419.73 in payments from pharmaceutical and medical device companies, with $87.46 received in 2023. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($419.73).
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location El Paso, TX
- Active Since 09/13/2019
- Last Updated 07/21/2025
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386294171
Products in Payments
- myRisk (Device) $124.59
- Optis Coronary Imaging System (Device) $24.26
- myChoice CDx (Device) $23.48
- PIQRAY (Drug) $15.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in El Paso
Dr. Cesar Abbud-Mendez, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $1,844
Dr. Khaled Sarah, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $1,141
Arturo Vargas, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $1,023
Hector Zepeda, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $580.04
Dr. Mohamad Hakim, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $386.65
Mariano Allen, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $305.92